Management Principles Associated With Cytokine Release Syndrome-Reference-Cited by-同舟云学术

Management Principles Associated With Cytokine Release Syndrome

Published:2019-10 Issue:5 Volume:35 Page:150931
ISSN:0749-2081
Container-title:Seminars in Oncology Nursing
language:en
Short-container-title:Seminars in Oncology Nursing

Author:

Baer Brittney,Dudley Channing Vail,Simons Rhea Micci

Publisher

Elsevier BV

Subject

Oncology(nursing)

Reference13 articles.

1. American Society of Clinical Oncology. Cancer progress timeline. Available at:https://www.asco.org/research-progress/cancer-progress-timeline. (Accessed 1 July 2019).

2. Yescarta (axicabtagene ciloleucel) package insert,2017

3. Kymriah (tisagenlecleucel) package insert,2017

4. Axicabtagene ciloleucel car T-cell therapy in refractory large b-cell lymphoma;Neelapu;N Engl J Med,2017

5. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncology nurse competency in chimeric antigen receptor T-cell therapy: A qualitative study;Nurse Education Today;2024-01

2. Toxicities of CAR T-cell therapy: a review of current literature;Annals of Medicine & Surgery;2023-10-20

3. Nursing Management in Pediatric Patients Undergoing Chimeric Antigen Receptor T (CAR-T) Cell Therapy: A Systematic Literature Review;Seminars in Oncology Nursing;2023-10

4. CAR T-Cell Therapy: Updates in Nursing Management;Clinical Journal of Oncology Nursing;2021-06-01

5. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events;Journal for ImmunoTherapy of Cancer;2020-12